UnitedHealth Group Inc. (NYSE:UNH) recently reported its preliminary financial results based on which CapitalCube provides a unique peer-based analysis of the company. Our analysis is based on the company's performance over the last 12 months (unless stated otherwise).
UnitedHealth Group Inc.'s analysis versus peers uses the following peer-set: AFLAC Inc. (NYSE:AFL), WellPoint Inc. (WLP), Aetna Inc. (NYSE:AET), Cigna Corporation (NYSE:CI), Sun Life Financial Inc. (NYSE:SLF) and Humana Inc. (NYSE:HUM). The table below shows the preliminary results along with the recent trend for revenues, net income and returns.
|Quarterly (USD million)||2012-09-30||2012-06-30||2012-03-31||2011-12-31||2011-09-30|
|Revenue Growth %||0.1||(0.1)||5.3||2.5||0.2|
|Net Income Growth %||16.5||(3.7)||10.3||(1.0)||0.3|
|Net Margin %||5.7||4.9||5.1||4.9||5.0|
|ROE % (Annualized)||20.9||18.4||19.6||18.2||18.7|
|ROA % (Annualized)||8.6||7.3||7.9||7.3||7.4|
UnitedHealth Group Inc.'s current Price/Book of 2.0 is about median in its peer group. UnitedHealth Group Inc.'s operating performance is higher than the median of its chosen peers (ROE of 19.2% compared to the peer median ROE of 15.7%) but the market does not seem to expect higher growth relative to peers (PE of 10.8 compared to peer median of 9.4) but simply to maintain its relatively high rates of return.
The company's capital efficiency (capital turns i.e.revenue/equity of 3.7x) and net profit margins of 5.1% are both median for its peer group. UnitedHealth Group Inc.'s net margin continues to trend upward and is now similar to its five-year average net margin of 4.8%.
The company enjoys both better than peer median annual revenue growth of 8.2% and better than peer median earnings growth performance 11.0%. UnitedHealth Group Inc. currently converts every 1% of change in annual revenue into 1.3% of change in annual reported earnings. We view this company as a leader among its peers.
UnitedHealth Group Inc.'s current return on equity is better than its peer median (19.2% vs. peer median 15.7%). However, its return on equity over the past five years has only been around the peer median (18.6% vs. peer median 18.6%). This performance suggests that the company may recently have found some new operational advantages to exploit relative to peers.
Growth And Investment Strategy
While UnitedHealth Group Inc.'s revenues have grown faster than the peer median (7.8% vs. 4.8% respectively for the past three years), the market gives the stock an about peer median PE ratio of 10.8. This suggests that the market has some questions about the company's long-term strategy.
UnitedHealth Group Inc.'s annualized rate of change in equity capital of 10.2% over the past three years is around its peer median of 10.2%. This median investment has likewise generated a peer median return on equity of 18.5% averaged over the same three years. This median return on investment implies that company is investing appropriately.
UnitedHealth Group Inc.'s reported net income margin for the last twelve months is around the peer median (5.1% vs. peer median of 4.9%). However, the company has also recorded a relatively low level of accruals (-0.4% vs. peer median of 6.1%) which suggests possible overstatement of its reported net income.
UnitedHealth Group Inc.'s accruals over the last twelve months are around zero. However, this modestly negative level is also less than the peer median which suggests some amount of draining of reserves.
UnitedHealth Group, Inc. provides health care coverage, software and data consultancy services. The company operates through four business segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. UnitedHealth Group was founded in January 1977 and is headquartered in Minnetonka, MN.
The information presented in this report has been obtained from sources deemed to be reliable, but AnalytixInsight does not make any representation about the accuracy, completeness, or timeliness of this information. This report was produced by AnalytixInsight for informational purposes only and nothing contained herein should be construed as an offer to buy or sell or as a solicitation of an offer to buy or sell any security or derivative instrument. This report is current only as of the date that it was published and the opinions, estimates, ratings and other information may change without notice or publication. Past performance is no guarantee of future results. Prior to making an investment or other financial decision, please consult with your financial, legal and tax advisors. AnalytixInsight shall not be liable for any party's use of this report. AnalytixInsight is not a broker-dealer and does not buy, sell, maintain a position, or make a market in any security referred to herein. One of the principal tenets for us at AnalytixInsight is that the best person to handle your finances is you. By your use of our services or by reading any our reports, you're agreeing that you bear responsibility for your own investment research and investment decisions. You also agree that AnalytixInsight, its directors, its employees, and its agents will not be liable for any investment decision made or action taken by you and others based on news, information, opinion, or any other material generated by us and/or published through our services. For a complete copy of our disclaimer, please visit our website analytixinsight.com.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.